Speaker illustration

Mr Daniel Ayoubkhani

Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)

The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure – Epidemiology, prognosis, outcome

Thumbnail

ESC 365 is supported by

logo Novo Nordisk